(Q42781340)
Statements
Phase II trial of combination of pegylated liposomal doxorubicin, cisplatin, and infusional 5-fluorouracil (CCF) plus trastuzumab as preoperative treatment for locally advanced and inflammatory breast cancer (English)
Giuseppe Viale
Aron Goldhirsch
Silvia Dellapasqua
Alberto Luini
Alessandra Balduzzi
Anna Cardillo
Raffaella Ghisini
Giuseppe Cancello